Xuelin (Steve) Wang
Lawyers
Filters
CIFI Holdings (Group) $300 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $300 million Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 5.950% senior notes due 2025.
Established in 2000…
Ocumension Therapeutics HK$1.55 billion IPO and HKEX listing
Davis Polk advised the underwriters in the initial public offering of Ocumension Therapeutics on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule…
Genetron Holdings $256 million IPO
Davis Polk advised Genetron Holdings Limited on its SEC-registered initial public offering of 16,000,000 American Depositary Shares. Each ADS represents five ordinary shares. Genetron has…
Zhenro Properties Group $200 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $200 million 8.300% senior notes due 2023.
Zhenro Properties Group…
Zhenro Properties Group $200 million high-yield notes offering and tender offer
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $200 million 8.350% senior notes due 2024.
Concurrently with the…
Akeso HK$2.44 billion IPO
Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S…
InnoCare Pharma HK$2.24 billion IPO
Davis Polk advised InnoCare Pharma Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…
Zhenro Properties Group $200 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $200 million 5.6% senior notes due 2021.
Zhenro Properties Group…
Zai Lab $300 million follow-on offering of ADSs
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…
Dexin China Holdings $200 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Dexin China Holdings Company Limited of $200 million 11.875% senior notes due 2022.
Dexin China…